Co-Diagnostics Inc
NASDAQ:CODX
Co-Diagnostics Inc
NASDAQ:CODX
Price:
1.1
USD
-12.7%
Market Cap:
$5.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Co-Diagnostics Inc
NASDAQ:CODX
|
US |
|
Key Petroleum Ltd
ASX:KEY
|
AU |
|
B
|
Brooker Group PCL
SET:BROOK
|
TH |
|
Banco Mercantil do Brasil SA
BOVESPA:BMEB4
|
BR |
|
Medondo Holding AG
F:AMI
|
DE |
|
Applus Services SA
MAD:APPS
|
ES |
|
Orphazyme A/S
CSE:ORPHA
|
DK |
|
N
|
NTF Intergroup (Thailand) PCL
SET:NTF
|
TH |
|
Max Resource Corp
XTSX:MAX
|
CA |
|
Subsea 7 SA
OSE:SUBC
|
UK |
|
CCSB Financial Corp
OTC:CCFC
|
US |
|
S
|
Safe Fertility Group PCL
SET:SAFE
|
TH |
|
S
|
Starr Peak Mining Ltd
XTSX:STE
|
CA |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CODX's stock price target?
Not Available
CODX does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Co-Diagnostics Inc?
Projected CAGR
120%
120%
Over the last 10 years, the compound annual growth rate for Revenue has been 51%. The projected CAGR for the next 8 years is 120%.
What is the Gross Profit forecast for Co-Diagnostics Inc?
Projected CAGR
123%
123%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 45%. The projected CAGR for the next 8 years is 123%.
